109 related articles for article (PubMed ID: 16934908)
1. Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines.
Kuhn H; Konrad J; Holtz S; Salameh A; Gessner C; Hammerschmidt S; Wirtz H
Lung Cancer; 2006 Nov; 54(2):149-53. PubMed ID: 16934908
[TBL] [Abstract][Full Text] [Related]
2. The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer.
Fu J; Ding Y; Huang D; Li H; Chen X
Cancer Lett; 2007 Apr; 248(1):153-63. PubMed ID: 17027148
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
4. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
6. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines.
Kuhn H; Köpff C; Konrad J; Riedel A; Gessner C; Wirtz H
Lung Cancer; 2004 May; 44(2):167-74. PubMed ID: 15084381
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.
Shikada Y; Yonemitsu Y; Koga T; Onimaru M; Nakano T; Okano S; Sata S; Nakagawa K; Yoshino I; Maehara Y; Sueishi K
Cancer Res; 2005 Aug; 65(16):7241-8. PubMed ID: 16103075
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Chen X; Xie Q; Cheng X; Diao X; Cheng Y; Liu J; Xie W; Chen Z; Zhu B
Cancer Sci; 2010 Nov; 101(11):2384-90. PubMed ID: 20825419
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.
Fenig E; Wieder R; Paglin S; Wang H; Persaud R; Haimovitz-Friedman A; Fuks Z; Yahalom J
Clin Cancer Res; 1997 Jan; 3(1):135-42. PubMed ID: 9815549
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of ampelopsin on angiogenesis].
Luo GQ; Zeng S; Liu DY
Zhong Yao Cai; 2006 Feb; 29(2):146-50. PubMed ID: 16617784
[TBL] [Abstract][Full Text] [Related]
12. Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.
Farhat FS; Tfayli A; Fakhruddin N; Mahfouz R; Otrock ZK; Alameddine RS; Awada AH; Shamseddine A
Crit Rev Oncol Hematol; 2012 Nov; 84(2):149-60. PubMed ID: 22494932
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
14. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
[TBL] [Abstract][Full Text] [Related]
15. Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells.
Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
Int J Mol Med; 2003 Jun; 11(6):785-90. PubMed ID: 12736723
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
[TBL] [Abstract][Full Text] [Related]
17. Effect of local neutralization of basic fibroblast growth factor or vascular endothelial growth factor by a specific antibody on the development of the corpus luteum in the cow.
Yamashita H; Kamada D; Shirasuna K; Matsui M; Shimizu T; Kida K; Berisha B; Schams D; Miyamoto A
Mol Reprod Dev; 2008 Sep; 75(9):1449-56. PubMed ID: 18213648
[TBL] [Abstract][Full Text] [Related]
18. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
[TBL] [Abstract][Full Text] [Related]
19. Enhanced angiogenesis with multimodal cell-based gene therapy.
Yau TM; Kim C; Li G; Zhang Y; Fazel S; Spiegelstein D; Weisel RD; Li RK
Ann Thorac Surg; 2007 Mar; 83(3):1110-9. PubMed ID: 17307468
[TBL] [Abstract][Full Text] [Related]
20. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
